Title : Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy.

Pub. Date : 2008 Oct

PMID : 18667486






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Podocyte loss and glomerular fibronectin accumulation, other markers of early DN, were prevented by rosiglitazone in both 12- and 24-wk diabetic models. Rosiglitazone fibronectin 1 Mus musculus